using the ventrogluteal site for intramuscular injections
Kathleen Greenway Senior Lecturer in Adult Nursing, Oxford Brookes University, Oxford
Clair Merriman Senior Lecturer in Clinical Skills, Oxford Brookes University, Oxford
Diane Statham Lecturer Practitioner in Learning Disability Nursing, Oxford Brookes University, Oxford
In this article, Kathleen Greenway, Clair Merriman and Diane Statham explore the role of the learning disability practitioner in administering intramuscular injections and the evidence base supporting the use of the ventrogluteal site. The professional issues facing learning disability practitioners in relation to topics such as rapid tranquillisation, physical interventions and consent are also discussed
The ideal site for administering intramuscular (IM) injections has been discussed in a number of recently published articles (Nisbet 2006, Greenway 2004, Small 2004). These authors consider the evidence that the traditional dorsogluteal (DG) (upper outer quadrant) should be avoided for most drugs; Greenway (2004) and Small (2004) suggest that the ventrogluteal site (VG) is the site of choice for IM injections.
Learning Disability Practice.
9, 8, 34-37.
doi: 10.7748/ldp2006.10.9.8.34.c7672
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
